• Jazz Pharmaceuticals average ebitda margin for 2023 was 23.66%, a 17.71% increase from 2022.
• Jazz Pharmaceuticals average ebitda margin for 2022 was 20.1%, a 34.23% increase from 2021.
• Jazz Pharmaceuticals average ebitda margin for 2021 was 30.56%, a 11.49% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.